This study evaluates the safety of not performing a sentinel node biopsy for patients 70 years of age or older with clinically node-negative breast cancer.
Findings from this retrospective review show the importance of removing the less radioactive nodes in patients with cutaneous melanoma.
This prospective feasibility trial adds selective removal of clip-containing lymph nodes to sentinel lymph node dissection, with the possibility of identifying patients for limited nodal surgery after chemotherapy.
Black et al determine racial differences in the use of sentinel lymph node biopsy among patients with pathologically node-negative breast cancer during the period when sentinel lymph node biopsy became the preferred method for axillary staging as well as whether such differences affect lymphedema risk. See the Invited Commentary by Murphy and Schulick.
Yen et al evaluate measures of surgical expertise, including the percentage of a surgeon’s operations for breast cancer, on the use of sentinel lymph node biopsy for invasive breast cancer. Zenilman provides an invited commentary.
Leung et al reviewed the records of patients with cutaneous melanoma who underwent completion lymph node dissection to evaluate whether disease limited to sentinel lymph nodes represents different clinical significance than disease spread into nonsentinel lymph nodes. See the invited commentary by Leong.